Corporate social networking site Mzinga buys Prospero
Workplace social networking company Mzinga has raised a hefty $32.5 million, and used some of that money to purchase a similar company called Prospero Technologies. Until now, Mzinga has focused on in-company social networks, but the acquisition should allow it to create similar offerings on the customer side, which is Prospero’s specialty.
The big gain for Mzinga appears to be Prospero’s social media technology, which allows companies to interact with their customers through social networking, advertising,… Continue Reading
Pelikan Tech to push “finger friendly” diabetes testing
One of the constant but unavoidable challenges in trying to control diabetes is the frequent need to test blood-sugar levels by sticking a needle into a fingertip — a step that tells diabetics when they need a snack (to raise blood glucose) or a shot of insulin (to lower it). “Lancing” fingers several times a day can render the tips so tender that it restricts ordinary activity — playing the piano, for instance — for… Continue Reading
Life sciences briefing: Monday, Aug. 27, 2007
Featured companies: Bravo Health, InfraReDx, MedAssets, Prestwick Pharmaceuticals
Prestwick Pharma raises $20M for neuro drugs — Specialty pharma Prestwick Pharmaceuticals, a Washington, D.C., firm that acquires cast-off drug candidates to treat neurological conditions, raised $20 million from existing investors, VentureWire reports (subscription required). Among those participating in the funding were Atlas Venture, Sofinnova Ventures, Vivo Ventures, Scale Venture Partners, Warburg Pincus and Pequot Ventures.
Prestwick said it raised the funds to acquire additional drug candidates. The company filed… Continue Reading